Results 31 to 40 of about 66,871 (301)

Follow-up study of sensory-motor polyneuropathy in Type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection [PDF]

, 1991
The influence of successful simultaneous pancreas and kidney transplantation on peripheral polyneuropathy was investigated in 53 patients for a mean observation period of 40.3 months. Seventeen patients were followed-up for more than 3 years.
Illner, Wolf-Dieter, Wagner, S., Nusser, J., Müller-Felber, W., Landgraf-Leurs, M. M. C., Land, Walter, Landgraf, R., Abendroth, D., Mair, N.   +8 more
core   +1 more source

Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs

The Pan African Medical Journal, 2016
INTRODUCTION: several risk factors including stavudine and age have been strongly associated with polyneuropathy. However, conflicting data exist on height as an independent risk factor in polyneuropathy.
Frank Ndaks Ndakala, Julius Otieno Oyugi, Margaret Ng'wono Oluka, Joshua Kimani, Alexandra Jablonka, Georg Martin Norbert Behrens   +5 more
doaj   +1 more source

The evaluation of polyneuropathies [PDF]

Neurology Clinical Practice, 2011
# {#article-title-2} We enjoyed reading the Burns et al.1 article about the evaluation of polyneuropathies but missed the discussion of critical illness polyneuropathy. It is the primary axonal degeneration of motor and sensory fibers that can lead to degeneration of muscle fibers.
Ted M, Burns, Michelle L, Mauermann
openaire   +5 more sources

Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy

Upsala Journal of Medical Sciences, 2022
Background: Although neuropathic pain is a significant problem in polyneuropathy, the underlying molecular mechanisms are poorly understood. The endogenous bioactive lipids 2-arachidonoyl-glycerol (2-AG), oleoylethanolamide (OEA), palmitoylethanolamide ...
Jonas Lind, Niclas Stensson, Björn Gerdle, Nazdar Ghafouri   +3 more
doaj   +1 more source

Increased Prevalence of Polyneuropathy in Parkinson’s Disease Patients: An Observational Study

Journal of Parkinson’s Disease, 2018
Background: The independent contribution of levodopa exposure and Parkinson’s disease (PD) to the risk of polyneuropathy is not established. Objective: This study investigated whether patients with newly diagnosed PD without previous exposure to ...
Christian Conradt, Dianlin Guo, Anca Miclea, Thomas Nisslein, Chaim Ismail, Krai Chatamra, Frank Andersohn   +6 more
doaj   +1 more source

AMPLITUDO SENSORY NEURON ACTION POTENTIAL USING AS INSTALLATION OF POLINEUROPATI DIAGNOSIS

Malang Neurology Journal, 2018
Background. Polyneuropathy is the pathologic changes and functional disturbances in the peripheral nervous system. These changes manifest as sign and symptoms such as numbness, burning, allodynia, atrophy, and lose of stimulation responses.
Billi Kinesya, Machlusil Husna, Shahdevi Nandar Kurniawan, Mochammad Ridwan   +3 more
doaj   +1 more source

Subclinical inflammation and diabetic polyneuropathy. [PDF]

, 2009
Subclinical inflammation represents a risk factor of type 2 diabetes and several diabetes complications, but data on diabetic neuropathies are scarce. Therefore, we investigated whether circulating concentrations of acute-phase proteins, cytokines, and ...
Lankisch, M., Illig, T., Martin, S., Herder, C., Döring, A., Rathmann, Wolfgang, Ziegler, D., Meisinger, Christa, Rathmann, W., Giani, G., Koenig, W., Thorand, B., Holle, R., Meisinger, C.   +13 more
core   +1 more source

Restless legs syndrome in patients with distal diabetic polyneuropathy [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2018
Introduction/Objective. An association between restless legs syndrome (RLS) and etiologically different polyneuropathies is well established. However, the investigations about the prevalence of RLS in diabetic polyneuropathy (DP) have led to controversy.
Smiljković Tatjana, Kostić-Dedić Svetlana, Nikolić Vesna, Gavrilović Anđela, Jevđić Sanja   +4 more
doaj   +1 more source

α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy

Медицинский совет, 2016
α-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves ...
I. A. Strokov, A. S. Phokina
doaj   +1 more source

Demystifying Polyneuropathy [PDF]

, 2019
Knowledge of the structure and function of the complex and interwoven network of nerves is inexhaustible and has not been fully determined. The physiological basis of many neuropathic symptoms continues to pursue experts in this field, and in many of the

core   +1 more source